Specifically, reduced ALDOB expression in gastric cancer tissues activates downstream glycolytic enzymes by lifting inhibition on the AKT signaling pathway, thereby promoting aerobic glycolysis, tumor growth, and metastasis. Here, AKT1 is linked to gastric cancer.